CANCER:

Retinoblastoma

News alerts, weekly reports and conference planners

No biomarker	Retinoblastoma	No biomarker	Retinoblastoma	cyclophosphamide Sensitive: A1 - Approval cyclophosphamide Sensitive : A1	cyclophosphamide Sensitive: A1 - Approval cyclophosphamide Sensitive : A1
BRD4 overexpression	Retinoblastoma	BRD4 overexpression	Retinoblastoma	JQ-1 Sensitive: D – Preclinical JQ-1 Sensitive : D	JQ-1 Sensitive: D – Preclinical JQ-1 Sensitive : D
B4GALNT1 expression	Retinoblastoma	B4GALNT1 expression	Retinoblastoma	CAR-T immunotherapy Sensitive: D – Preclinical CAR-T immunotherapy Sensitive : D	CAR-T immunotherapy Sensitive: D – Preclinical CAR-T immunotherapy Sensitive : D
PRMT5 overexpression	Retinoblastoma	PRMT5 overexpression	Retinoblastoma	EPZ015666 Sensitive: D – Preclinical EPZ015666 Sensitive : D	EPZ015666 Sensitive: D – Preclinical EPZ015666 Sensitive : D

Associations(4)